Placenta-derived multipotent cells differentiate into neuronal and glial cells in vitro

Area of Science:

• Stem cell biology
• Neuroscience
• Regenerative medicine

Background:

• Current stem cell sources face ethical and biological limitations.
• Placenta-derived multipotent cells (PDMCs) are an ethically unproblematic and accessible stem cell source.
• PDMCs have previously shown potential for differentiating into mesenchymal lineages.

Purpose of the Study:

• To investigate the potential of PDMCs to differentiate into all three major neural cell types.
• To explore various induction methods for neural differentiation of PDMCs.
• To assess the suitability of PDMCs for neural cell therapy.

Main Methods:

• PDMCs were isolated from human term placenta.
• Neural differentiation was induced using retinoic acid (RA), 1-methyl-3-isobutylxanthine (IBMX), and co-culture with neonatal rat brain cells.
• Neural differentiation was assessed by morphological changes and expression of neural markers.

Main Results:

• PDMCs successfully differentiated into neuron-like cells, exhibiting process outgrowth and expressing neuron-specific enolase.
• Co-culture with neonatal rat brain cells also promoted neural differentiation.
• PDMCs demonstrated the capacity to differentiate into neurons, astrocytes, and oligodendrocytes.

Conclusions:

• PDMCs can be induced to differentiate into various neural cell types of the human nervous system.
• The placenta is a viable source for multipotent cells with neural differentiation potential.
• PDMCs represent a promising cell source for neurological applications and therapies.